Abstract | BACKGROUND: The increased susceptibility to latent tuberculosis infection (LTBI) of HIV-1-infected persons represents a challenge in TB epidemic control. However few studies have evaluated LTBI predictors in a generalized HIV/TB epidemic setting. METHODS: The study recruited 335 HIV-infected participants from Khayelitsha, Cape Town between February 2008 and November 2010. Tuberculin skin tests and interferon-gamma release assays were performed on all participants and active TB excluded using a symptom screen, TB microscopy and culture. RESULTS: LTBI prevalence was 52.7% and 61.2% (TST and IGRA respectively). Being a recent TB contact (OR 2.07; 95% C.I. 1.15-3.69) was associated with TST positivity. Participants with a CD4>200 had a two-fold higher risk of IGRA positivity compared to those with CD4 counts <200 (OR 2.07; 95% C.I. 0.99-4.34). There was also a 19% increase in IGRA positivity risk for every additional year of schooling and a strong association between years of schooling and employment (p = 0.0004). A decreased risk of IGRA positivity was observed in persons with a BCG scar (OR 0.46; 95% C.I. 0.31-0.69) and in smokers (OR 0.47; 95% C.I. 0.23-0.96). CONCLUSION: We report the novel findings of a decreased risk of IGRA positivity in HIV-infected smokers possibly due to decreased interferon production, and in the persons with a BCG scar suggesting a protective role for BCG in this population. We also found an increased risk of TST positivity in employed persons, possibly due to ongoing transmission in public modes of transport.
|
Authors | Tolu Oni, Hannah P Gideon, Nonzwakazi Bangani, Relebohile Tsekela, Ronnett Seldon, Kathryn Wood, Katalin A Wilkinson, Rene T Goliath, Tom H M Ottenhoff, Robert J Wilkinson |
Journal | PloS one
(PLoS One)
Vol. 7
Issue 10
Pg. e47072
( 2012)
ISSN: 1932-6203 [Electronic] United States |
PMID | 23056584
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Topics |
- Adult
- Employment
- Female
- HIV Infections
(epidemiology, immunology)
- Humans
- Interferon-gamma Release Tests
- Male
- Mycobacterium bovis
(immunology)
- Smoking
(adverse effects)
- South Africa
(epidemiology)
- Tuberculin Test
- Tuberculosis
(epidemiology, immunology)
|